Serious arterial thromboembolic events (sATE) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizurnab (BV): results from the BRITE registry

被引:0
|
作者
Sing, A. [1 ]
Sugrue, M. [1 ]
Chiruvolu, R. [1 ]
Yi, J. [1 ]
Purdie, D. [1 ]
Dong, W. [1 ]
Grothey, A. [2 ]
Kozloff, M. [3 ]
机构
[1] Genentech Inc, San Francisco, CA USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ Chicago, Ingalls Hosp, Harvey, KS USA
来源
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词
D O I
10.1016/S1359-6349(07)70973-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3045
引用
收藏
页码:249 / 249
页数:1
相关论文
共 50 条
  • [1] Serious arterial thromboembolic events (sATE) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV): Results from the BRiTE registry
    Sugrue, M. M.
    Yi, J.
    Purdie, D.
    Dong, W.
    Grothey, A.
    Kozloff, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Serious arterial thromboembolic events (sATE) in patients (PTS) with metastatic colorectal cancer (MCRC) treated with bevacizumab (BV): Results from the BRiTE registry
    Sugrue, M.
    Yi, J.
    Purdie, D.
    Dong, W.
    Grothey, A.
    Kozoff, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII30 - VII30
  • [3] Incidence of serious bleeding events (sBE) in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV) as part of a first-line regimen: Results from the BRiTE observational cohort study (OCS)
    Flynn, P. J.
    Sugrue, M. M.
    Feng, S.
    Purdie, D. M.
    Grothey, A.
    Sargent, D. J.
    Berlin, J. D.
    Kabbinavar, F. F.
    Dong, W.
    Kozloff, M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): Results from the BRiTE observational cohort study
    Kozloff, M. F.
    Sugrue, M. M.
    Purdie, D. M.
    Berlin, J. D.
    Flynn, P. J.
    Kabbinavar, F. F.
    Sargent, D. J.
    Dong, W.
    Grothey, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Serious wound healing complications (sWHC) following surgery in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV): Results from the BRiTE observational cohort study (OCS)
    Sugrue, M. M.
    Purdie, D. M.
    Feng, S.
    Flynn, P. J.
    Grothey, A.
    Sargent, D. J.
    Berlin, J. D.
    Kabbinavar, F. F.
    Dong, W.
    Kozloff, M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Clinical outcomes in bevacizumab (BV)-treated patients (pts) with metastatic colorectal cancer (mCRC): Results from ARIES observational cohort study (OCS) and confirmation of BRITE data on BV beyond progression (BBP)
    Cohn, A. L.
    Bekaii-Saab, T.
    Bendell, J. C.
    Hurwitz, H.
    Kozloff, M.
    Roach, N.
    Tezcan, H.
    Feng, S.
    Sing, A.
    Grothey, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] ADVERSE EVENTS (AES) ASSOCIATED WITH BEVACIZUMAB (BV) IN OLDER PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Shankaran, V.
    Mummy, D.
    Koepl, L.
    Blough, D.
    Yim, Y. M.
    Yu, E.
    Ramsey, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 203 - 203
  • [8] Treatment center (TC) variability in survival of patients (pts) with colorectal cancer (mCRC) treated with bevacizumab (BV): A subanalysis from the BRiTE Observational Study (OCS)
    Barron, H. V.
    Purdie, D. M.
    Feng, S.
    Sing, A. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients with metastatic colorectal cancer (MCRC): Results from the BRiTE observational cohort study
    Kozloff, M.
    Sugrue, M.
    Chiruvolu, P.
    Purdie, D.
    Berlin, J.
    Flynn, P.
    Kabbinavar, F.
    Sargent, D.
    Dong, W.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 26 - 26
  • [10] Management of hypertension (HTN) in patients (pts) with metastatic colorectal cancer (MCRC) treated with bevacizumab (BV) plus chemotherapy (CT)
    Kozloff, M.
    Hainsworth, J.
    Badarinath, S.
    Cohn, A.
    Flynn, P.
    Dong, W.
    Suzuki, S.
    Purdie, D.
    Yi, J.
    Sugrue, M.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2007, 18 : VII80 - VII80